Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 3001 AL 3015

A PDE10A de novo mutation causes childhood-onset chorea with diurnal fluctuations

Esposito S, Carecchio M, Tonduti D, Saletti V, Panteghini C, Chiapparini L, Zorzi G, Pantaleoni C, Garavaglia B, Krainc D, Lubbe SJ, Nardocci N, Mencacci NE.

Mov Disord. 2017 Nov;32(11):1646-1647. doi: 10.1002/mds.27175. Epub 2017 Sep 26.

Metal complexes for multimodal imaging of misfolded protein-related diseases

Lacerda S, Morfin JF, Geraldes CFGC, Tóth É.

Dalton Trans. 2017 Oct 31;46(42):14461-14474. doi: 10.1039/c7dt02371e.

[Effectiveness of levodopa treatment for diabetic chorea with reduced striatal accumulation in dopamine transporter SPECT: a case report]

Yokoi K, Kazuta T, Torii R, Endo T, Araki A, Terao S.

Rinsho Shinkeigaku. 2017 Oct 27;57(10):591-594. doi: 10.5692/clinicalneurol.cn-001041. Epub 2017 Sep 28.

Current Understanding of PDE10A in the Modulation of Basal Ganglia Circuitry

Schülke JP, Brandon NJ.

Adv Neurobiol. 2017;17:15-43. doi: 10.1007/978-3-319-58811-7_2.

Role of Phosphodiesterases in Huntington's Disease

Fusco FR, Paldino E.

Adv Neurobiol. 2017;17:285-304. doi: 10.1007/978-3-319-58811-7_11.

The Neuropsychology of Huntington's Disease

Snowden JS.

Arch Clin Neuropsychol. 2017 Nov 1;32(7):876-887. doi: 10.1093/arclin/acx086.

Chorea Minor Associated with Anti-Neurochondrin Autoantibodies

Rommel FR, Miske R, Stöcker W, Arneth B, Neubauer BA, Hahn A.

Neuropediatrics. 2017 Dec;48(6):482-483. doi: 10.1055/s-0037-1606371. Epub 2017 Sep 29.

Reliability and Validity of the HD-PRO-TriadTM, a Health-Related Quality of Life Measure Designed to Assess the Symptom Triad of Huntington's Disease

Boileau NR, Stout JC, Paulsen JS, Cella D, McCormack MK, Nance MA, Frank S, Lai JS, Carlozzi NE.

J Huntingtons Dis. 2017;6(3):201-215. doi: 10.3233/JHD-170238.

Physical Therapy and Exercise Interventions in Huntington's Disease: A Mixed Methods Systematic Review

Fritz NE, Rao AK, Kegelmeyer D, Kloos A, Busse M, Hartel L, Carrier J, Quinn L.

J Huntingtons Dis. 2017;6(3):217-235. doi: 10.3233/JHD-170260.

Clinical Trials Corner: September 2017

Rodrigues FB, Wild EJ.

J Huntingtons Dis. 2017;6(3):255-263. doi: 10.3233/JHD-170262.

Unilateral Thalamic Infarct Presenting as a Convulsive Seizure

Kumar R, Brohi H, Mughul A.

J Coll Physicians Surg Pak. 2017 Sep;27(9):S104-S105.

Molecular Chaperones in Neurodegenerative Diseases: A Short Review

Bobori C, Theocharopoulou G, Vlamos P.

Adv Exp Med Biol. 2017;987:219-231. doi: 10.1007/978-3-319-57379-3_20.

Survival End Points for Huntington Disease Trials Prior to a Motor Diagnosis

Long JD, Mills JA, Leavitt BR, Durr A, Roos RA, Stout JC, Reilmann R, Landwehrmeyer B, Gregory S, Scahill RI, Langbehn DR, Tabrizi SJ; Track-HD and Track-On Investigators.

JAMA Neurol. 2017 Nov 1;74(11):1352-1360. doi: 10.1001/jamaneurol.2017.2107.

Genetic modifiers of Mendelian disease: Huntington's disease and the trinucleotide repeat disorders

Holmans PA, Massey TH, Jones L.

Hum Mol Genet. 2017 Oct 1;26(R2):R83-R90. doi: 10.1093/hmg/ddx261.

Editorial: Pathophysiology of the Basal Ganglia and Movement Disorders: Gaining New Insights from Modeling and Experimentation, to Influence the Clinic

Andres DS, Merello M, Darbin O.

Front Hum Neurosci. 2017 Sep 20;11:466. doi: 10.3389/fnhum.2017.00466. eCollection 2017.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias